BioSpace News Archive

Can-Fite BioPharma Ltd today announced that Alimentary Pharmacology & Therapeutics published an article titled “ Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis” authored by Can-Fite’s CEO Dr. Pnina Fishman.

Renalytix plc announces its results for the twelve months ended 30 June 2021.

OpGen, Inc today announced that its subsidiary Ares Genetics has commercially launched its AREScloud web application.

ITOCO INC. (OTC PINK:ITMC) is pleased to welcome Maria Teresa Tattersfield Yarza to its Board of Directors.

Gilead Presents Long-Term Switch Data Reinforcing Biktarvy ® as a Treatment Option for a Broad Range of People Living With HIV

Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide a business update for the third quarter ended September 30, 2021, before the US markets open on Thursday, November 4, 2021.

Athenex today announced that the Company will provide a corporate and financial update for the third quarter 2021, on Friday, November 5, 2021, before the market opens.

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that Ilan Ganot, Co-Founder, President and Chief Executive Officer, and Carl Morris, PhD, Chief Scientific Officer, will participate in a fireside chat at the Jefferies Gene Therapy/Editing Summit

Revolo Biotherapeutics announced today that a clinical study has been activated and patient enrollment is underway in a Phase 2 allergen sensitivity study in the UK evaluating the safety and efficacy of its first-in-class peptide

Cocrystal Pharma, Inc. announces that President and co-interim CEO Dr. Sam Lee will present new data from its COVID-19 programs at the World Antiviral Congress 2021 being held in San Diego.